Updates

Date: 4th September, 2026 The Manager, The Manager, Corporate Filings Department, Listing Compliance Department, BSE Limited, National Stock Exchange of India Ltd. Phiroze Jeejeebhoy Towers, Exchange Plaza, Plot no. C/1, G Block, Dalal Street, Bandra-Kurla Complex, Bandra (E), Mumbai- 400 001. Mumbai - 400 051. Security Code: 532815 Symbol: SMSPHARMA Dear Sir/Madam, Sub: Business Responsibility and Sustainability Report for the financial year 2025-26. Pursuant to Regulation 34(2)(f) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith the Business Responsibility and Sustainability Report (BRSR) of the Company for the financial year 2025-26. The BRSR also forms part of the Annual Report for the Financial Year 2025-26. Please take the above intimation on your records. Thanking you Yours faithfully For SMS Pharmaceuticals Limited Thirumalesh Tumma Company Secretary and Compliance Officer Encl: as above SMS Pharmaceuticals Limited Corporate Overview Statutory Reports Financial Statements Annual Report 2025-26 02-37 38-126 127-253 BUSINESS RESPONSIBILITY & SUSTAINABILITY REPORT (BRSR) – 2025-26 SECTION A: GENERAL DISCLOSURES I. Details of the listed entity 1. Corporate Identity Number (CIN) of the Listed Entity : L24239TG1987PLC008066 2. Name of the Listed Entity : SMS Pharmaceuticals Limited 3. Year of incorporation : 14th December, 1987 4. Registered office address : 8th Floor, Trendset Jayabheri Connect, Kondapur Serilingampally, Ranga Reddy Dist., Hyderabad-500084, Telangana. India 5. Corporate address : 8th Floor, Trendset Jayabheri Connect, Kondapur Serilingampally, Ranga Reddy Dist., Hyderabad-500084, Telangana. India 6. E-mail : cs@smspharma.com 7. Telephone : +91 - 40 – 6985 9999 8. Website : www.smspharma.com 9. Financial year for which reporting is being done : 01st April, 2025 to 31st March, 2026 10. Name of the Stock Exchange(s) where shares are listed : BSE Limited (BSE), National Stock Exchange of India Limited (NSE) 11. Paid-up Capital : Rs.936.52 lakhs 12. Name and contact details telephone, email address) of the : Mr. Thirumalesh Tumma, Company Secretary and Compliance person who may be contacted in case of any queries on the Officer, Tele: +91 - 40 – 6985 9999, BRSR report Email:Complianceofficer@smspharma.com 13. Reporting boundary - Are the disclosures under this Report : The disclosure under BRSR is on Standalone basis unless made on a standalone basis or on a consolidated basis. otherwise stated. 14. Name of assurance provider : - 15. Type of assurance obtained : - II. Products/services 16. Details of business activities (accounting for 90% of the turnover): Description of Main Activity Description of Business Activity % of Turnover of the entity 1. Manufacturing Manufacture of Active Pharmaceutical Ingredients (APIs) 99.21 17. Products/Services sold by the entity (accounting for 90% of the entity’s Turnover): S. % of total Turnover Product/Service NIC Code No. contributed 1. Manufacture of Active pharma 21001 100 ingredients, intermediates, custom pharmaceutical products 94 95 SMS Pharmaceuticals Limited Corporate Overview Statutory Reports Financial Statements Annual Report 2025-26 02-37 38-126 127-253 III. Operations 18. Number of locations where plants and/or operations/offices of the entity are situated: Location Number of plants Number of offices Total National 3* 1 4 International 0 0 0 *The plants include the Company’s manufacturing locations and R&D centers. 19. Markets served by the entity: a. Number of locations Locations Number National (No. of States) 20 International (No. of Countries) 45 b. What is the contribution of exports as a percentage of the total turnover of the entity? c. A brief on types of customers We serve a diverse range of pharmaceutical companies worldwide. IV. Employees 20. Details as at the end of Financial Year: a. Employees and workers (including differently abled): S. Male Female Particulars Total (A) No. No (B) % (B/A) No (C) % (C/A) EMPLOYEES 1. Permanent (D) 1266 1183 93.44 83 6.56 2. Other than Permanent (E) - - - - - 3. Total employees (D + E) 1266 1183 93.44 83 6.56 WORKERS 4. Permanent (F) 351 351 100 - - 5. Other than Permanent (G) 471 414 87.90 57 12.10 6. Total workers (F + G) 822 765 93.07 57 6.93 b. Differently abled Employees and workers: S. Male Female Particulars Total (A) No. No (B) % (B/A) No (C) % (C/A) DIFFERENTLY ABLED EMPLOYEES 1. Permanent (D) - - - - - 2. Other than Permanent (E) - - - - - 3. Total differently abled employees (D + E) - - - - - DIFFERENTLY ABLED WORKERS 4. Permanent (F) - - - - - 5. Other than permanent (G) - - - - - 6. Total differently abled workers (F + G) - - - - - 94 95 SMS Pharmaceuticals Limited Corporate Overview Statutory Reports Financial Statements Annual Report 2025-26 02-37 38-126 127-253 21. Participation/ Inclusion/representation of Women No. and percentage of Females Particulars Total (A) No (B) % (B/A) Board of Directors 8 1 12.5 Key Management Personnel 4 0 0 22. Turnover rate for permanent employees and workers (Disclose trends for the past 3 years) Turnover rate in current Turnover rate in previous Turnover rate in the FY prior Particulars FY 2025-26 FY 2024-25 to previous FY 2023-24 Male Female Total Male Female Total Male Female Total Permanent Employees 16.37 45.33 18.16 5.68 9.58 15.26 22.99 25.24 48.23 Permanent Workers 21.07 0 21.07 8.99 0 8.99 26.75 0 26.75 V. Holding, subsidiary and Associate Companies (including Joint Ventures) 23. (a) Names of holding / subsidiary / associate companies / joint ventures Does the entity indicated at column Name of the holding/ subsidiary/ Indicate whether % of shares S. A, participate in the Business associate companies/ joint ventures holding/Subsidiary/ held by listed No. Responsibility initiatives of the (A) Associate/ Joint Venture entity listed entity? (Yes/No) 1 SMS coLab Private Limited Wholly Owned 100.00 No Subsidiary 2 SMS Peptides Private Limited Subsidiary 99.99 No 3 VKT Pharma Private Limited Associate 34.83 No 4 CHEMO SMS ENTERPRISES SL (55% Joint Venture 45.00 No held by Chemo 45% held by SMS) VI. CSR Details 24. (i) Whether CSR is applicable as per section 135 of Companies Act, 2013: Yes (ii) Turnover (in Rs.) 886,87,10,488/- (iii) Net worth (in Rs.) 804,78,68,581/- VII. Transparency and Disclosures Compliances 25. Complaints/Grievance on any of the principles (Principles1 to 9) under the National Guidelines on Responsible Business conduct Grievance Redressal FY 2025-26 FY 2024-25 Stakeholder group from Mechanism in Place (Yes/ Number of Number of Number of Number of whom complaint is No) (If yes, then provide complaints complaints pending complaints complaints Remarks Remarks received web-link for grievance filed during resolution at close filed during pending resolution redress policy)* the year of the year the year at close of the year Communities Y - - - - - - Investors (other than Y - - - - - - shareholders) Shareholders Y - - - - - - Employees and workers Y - - - - - - 96 97 SMS Pharmaceuticals Limited Corporate Overview Statutory Reports Financial Statements Annual Report 2025-26 02-37 38-126 127-253 Customers Y - - - - - - Value Chain Partners Y - - - - - - Other (please specify) - - - - - - - *Various policies of the Company for redressing the grievances of its stakeholders are available at https://smspharma.com/company-announcements/ downloads/ In addition there are internal policies placed on intranet of the Company. 26. Overview of the entity’s material responsible business conduct issues Please indicate material responsible business conduct and sustainability issues pertaining to environmental and social matters that present a risk or an opportunity to your business, rationale for identifying the same, approach to adapt or mitigate the risk along with its financial implications per the following format: Financial implications of In case of risk, S. Indicate whether risk or [Showing first 8,000 characters — download PDF for full document]